ArticleFrontiers in medicine2025
Incidence and risk factors for postoperative nausea and vomiting following video-assisted thoracoscopic surgery: a prospective observational study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Predictors of Recurrence Following Bronchial Artery Embolisation (BAE) for Haemoptysis: A Systematic Review and Evidence Synthesis Analyses Using SWiM Guidelines.Cardiovascular and interventional radiology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative nausea and vomiting (PONV) is a common complication after general anesthesia, contributing to patient discomfort, adverse clinical outcomes, and increased healthcare costs. While video-assisted thoracoscopic surgery (VATS) offers substantial benefits over open procedures, data on the incidence and predictors of PONV specifically following VATS are scarce and predominantly derived from retrospective studies. This study aimed to prospectively determine the incidence and identify independent risk factors for PONV within the first 72 h after VATS. Methods: In this single-center, prospective observational study, we enrolled 355 adult patients (aged ≥ 18 years) who underwent VATS under general anesthesia at Peking University Third Hospital between September 2022 and September 2023. PONV was assessed in the post-anesthesia care unit (PACU) within 2 h postoperatively and then daily on the ward for three consecutive days. The primary outcome was the incidence of PONV within 72 h. Multivariate logistic regression was employed to identify independent risk factors, with a Results: The overall incidence of PONV within 72 h was 19.44% (69/355). PONV was significantly more frequent in female patients (84.06% of PONV cases) than in males (15.94%, Conclusion: Approximately one in five patients experienced PONV within 72 h after VATS. Independent risk factors included female gender, preoperative ESPB, omission of preoperative steroid prophylaxis, and low intraoperative minimum MAP. These findings highlight potential targets for risk stratification and optimized PONV prophylaxis in this surgical population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.